A decent Q2 performance, but North America remains a pain-point
01/08/24 -"Bic’s Q2 FY24 performance was stronger than the market’s expectations – revenue was slightly below but EPS and FCF were ahead. On a comparable basis, the group’s revenue declined by 0.9% yoy ..."
Pages
56
Language
English
Published on
01/08/24
You may also be interested by these reports :
03/11/25
Puig delivered an impressive Q3 25, beating expectations with extraordinary momentum in makeup and solid progress in Asia. The group raised its FY25 ...
30/10/25
Haleon’s Q3 sales aligned with expectations, driven by growth in Oral Health, VMS, Pain Relief, and Digestive Health. This was partially offset by ...
30/10/25
Essity delivered a profit beat for Q3 2025, with an Adj. EBITA of SEK 5,056m and an impressive 14.6% margin, exceeding consensus despite in-line net ...
29/10/25
Reckitt delivered estimate-beating Q3 2025 sales of £3.61bn, up a robust 7.0%, driven by sequential volume improvements and solid emerging markets ...